Development and Evaluation of Novel Drug Delivery Systems for Targeted Cancer Therapy

Thesis Abstract

Abstract
Cancer remains a significant global health challenge, necessitating continuous research and innovation in the field of oncology. This thesis focuses on the development and evaluation of novel drug delivery systems for targeted cancer therapy. The aim of this research is to address the limitations of traditional cancer treatment approaches by designing innovative drug delivery systems that can specifically target cancer cells while minimizing side effects on healthy tissues. The study incorporates a multidisciplinary approach, integrating principles of pharmacy, nanotechnology, and oncology to advance the field of cancer therapy. The introduction provides a comprehensive overview of the current landscape of cancer treatment, highlighting the shortcomings of existing therapies and the need for targeted drug delivery systems. The background of the study delves into the molecular mechanisms of cancer development and progression, emphasizing the importance of targeted therapy in improving treatment outcomes. The problem statement identifies the gaps in current cancer treatment approaches and sets the stage for the development of novel drug delivery systems. The objectives of the study include the design and synthesis of targeted drug delivery systems, evaluation of their efficacy in vitro and in vivo, and comparison with conventional cancer treatment modalities. The limitations of the study are acknowledged, including potential challenges in scaling up the production of novel drug delivery systems and obtaining regulatory approval for clinical use. The scope of the study is outlined, focusing on specific types of cancer and drug delivery mechanisms. The significance of the study lies in its potential to revolutionize cancer therapy by enhancing treatment efficacy and reducing adverse effects. By targeting cancer cells specifically, these novel drug delivery systems have the potential to improve patient outcomes and quality of life. The structure of the thesis is detailed, outlining the chapters and sub-sections that will be covered in the research. The literature review critically examines existing research on drug delivery systems for cancer therapy, highlighting recent advances and identifying gaps in knowledge. Key topics include nanotechnology-based drug delivery, targeted therapy approaches, and the challenges of drug resistance in cancer treatment. The research methodology section describes the experimental design, materials and methods used for drug synthesis and evaluation, and statistical analysis techniques employed. The findings of the study are discussed in detail, presenting the results of in vitro and in vivo experiments, comparisons with conventional therapies, and insights into the mechanisms of action of the novel drug delivery systems. The implications of the findings for cancer treatment are explored, emphasizing the potential clinical applications and future directions for research in this field. In conclusion, this thesis contributes to the advancement of cancer therapy by developing and evaluating novel drug delivery systems for targeted treatment. The research outcomes have the potential to significantly impact the field of oncology, offering new possibilities for personalized and effective cancer care. This study represents a critical step towards improving cancer treatment outcomes and addressing the challenges associated with current therapeutic approaches.